Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

1994 • 3,408 citations

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

1994 • 2,993 citations

Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1994 • 2,250 citations

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1994 • 2,186 citations

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

1994 • 2,115 citations

ACC/AHA guidelines for the management of patients with acute myocardial infarction

1996 • 1,888 citations

A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease

1997 • 1,447 citations

Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes

1998 • 1,395 citations

Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study

1997 • 1,346 citations

Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study

1999 • 1,296 citations

Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction

1998 • 1,263 citations

Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction

1999 • 1,077 citations

ACC/AHA guidelines for the management of patients with acute myocardial infarction

1996 • 964 citations

Outcomes in Patients with Acute Non–Q-Wave Myocardial Infarction Randomly Assigned to an Invasive as Compared with a Conservative Management Strategy

1998 • 815 citations

A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable Angina

1998 • 771 citations

A comparison of recombinant Hirudin with Heparin for the treatment of acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators

1996 • 719 citations

Twelve-Year Follow-up of Survival in the Randomized European Coronary Surgery Study

1988 • 713 citations

Low-molecular-weight heparin during instability in coronary artery disease

1996 • 682 citations

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

1996 • 631 citations

Comparison of Low-Molecular-Weight Heparin With Unfractionated Heparin Acutely and With Placebo for 6 Weeks in the Management of Unstable Coronary Artery Disease

1997 • 544 citations

Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial

1997 • 534 citations

Unstable Angina

1990 • 508 citations

Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis

1996 • 433 citations

Acute Coronary Syndromes

1998 • 360 citations

Adding Heparin to Aspirin Reduces the Incidence of Myocardial Infarction and Death in Patients With Unstable Angina

1996 • 347 citations

One-year results of the thrombolysis in myocardial infarction (TIMI) IIIB clinical trial

1995 • 346 citations

Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators.

1999 • 341 citations

Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study

1999 • 325 citations

Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial

1999 • 319 citations

Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome)

1999 • 259 citations

The Myth of the Myocardial ‘Infarctlet’ During Percutaneous Coronary Revascularization Procedures

1996 • 140 citations

Minimal myocardial damage during coronary intervention is associated with impaired outcome

1999 • 108 citations

Adding Heparin to Aspirin Reduces the Incidence of Myocardial Infarction and Death in Patients with Unstable Angina

1997 • 28 citations

THE HEALTH CARE BURDEN OF UNSTABLE ANGINA

1999 • 17 citations

Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6 day treatment of unfractioned heparin in the initial management of unstable angina or no Q wawe myocardial infarction

1999 • 2 citations

Unstable angina. Introduction.

1999 • 1 citations